Cargando…

Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas

BACKGROUND: Enterocutaneous fistulas (ECF) pose a major challenge to every gastrointestinal (GI) surgeon. Based on earlier studies, a standardized treatment guideline was implemented. The focus of the present study was to assess that guideline and determine prognostic factors for outcome of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Visschers, Ruben G. J., Damink, Steven W. M. Olde, Winkens, Bjorn, Soeters, Peter B., van Gemert, Wim G.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248608/
https://www.ncbi.nlm.nih.gov/pubmed/18175171
http://dx.doi.org/10.1007/s00268-007-9371-1
_version_ 1782151019774345216
author Visschers, Ruben G. J.
Damink, Steven W. M. Olde
Winkens, Bjorn
Soeters, Peter B.
van Gemert, Wim G.
author_facet Visschers, Ruben G. J.
Damink, Steven W. M. Olde
Winkens, Bjorn
Soeters, Peter B.
van Gemert, Wim G.
author_sort Visschers, Ruben G. J.
collection PubMed
description BACKGROUND: Enterocutaneous fistulas (ECF) pose a major challenge to every gastrointestinal (GI) surgeon. Based on earlier studies, a standardized treatment guideline was implemented. The focus of the present study was to assess that guideline and determine prognostic factors for outcome of patients with ECF, and to define a more detailed therapeutic approach including the convalescence time before restorative surgery. METHODS: All patients with ECF treated between 1990 and 2005 were included. Management consisted of controlling Sepsis, Optimization of nutritional state, Wound care, assessment of fistula Anatomy, Timing of surgery, and Surgical strategy (the SOWATS guideline). Prognostic factors were assessed by way of multiple logistic regression analysis. RESULTS: A total of 135 patients were treated at our unit. Overall closure was achieved in 118 patients (87.4%). Restorative operations for fistula closure were performed after a median of 53 days (range: 4–270 days). Restorative operations were successful in 97/107 patients (90.7%). Thirteen patients (9.6%) died. An abdominal wall defect was the most predominant negative prognostic factor for spontaneous closure (odds ratio [OR] = 0.195, confidence interval [CI] 0.052–0.726, p = 0.015). A strong relation was found between preoperative albumin level and surgical closure (p < 0.001) and mortality (p < 0.001). CONCLUSIONS: Application of the SOWATS guideline allowed a favorable outcome after a short convalescence period. Abdominal wall defects and preoperative hypoalbuminemia are important prognostic variables.
format Text
id pubmed-2248608
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-22486082008-02-22 Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas Visschers, Ruben G. J. Damink, Steven W. M. Olde Winkens, Bjorn Soeters, Peter B. van Gemert, Wim G. World J Surg Article BACKGROUND: Enterocutaneous fistulas (ECF) pose a major challenge to every gastrointestinal (GI) surgeon. Based on earlier studies, a standardized treatment guideline was implemented. The focus of the present study was to assess that guideline and determine prognostic factors for outcome of patients with ECF, and to define a more detailed therapeutic approach including the convalescence time before restorative surgery. METHODS: All patients with ECF treated between 1990 and 2005 were included. Management consisted of controlling Sepsis, Optimization of nutritional state, Wound care, assessment of fistula Anatomy, Timing of surgery, and Surgical strategy (the SOWATS guideline). Prognostic factors were assessed by way of multiple logistic regression analysis. RESULTS: A total of 135 patients were treated at our unit. Overall closure was achieved in 118 patients (87.4%). Restorative operations for fistula closure were performed after a median of 53 days (range: 4–270 days). Restorative operations were successful in 97/107 patients (90.7%). Thirteen patients (9.6%) died. An abdominal wall defect was the most predominant negative prognostic factor for spontaneous closure (odds ratio [OR] = 0.195, confidence interval [CI] 0.052–0.726, p = 0.015). A strong relation was found between preoperative albumin level and surgical closure (p < 0.001) and mortality (p < 0.001). CONCLUSIONS: Application of the SOWATS guideline allowed a favorable outcome after a short convalescence period. Abdominal wall defects and preoperative hypoalbuminemia are important prognostic variables. Springer-Verlag 2008-01-04 2008-03 /pmc/articles/PMC2248608/ /pubmed/18175171 http://dx.doi.org/10.1007/s00268-007-9371-1 Text en © The Author(s) 2007
spellingShingle Article
Visschers, Ruben G. J.
Damink, Steven W. M. Olde
Winkens, Bjorn
Soeters, Peter B.
van Gemert, Wim G.
Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas
title Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas
title_full Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas
title_fullStr Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas
title_full_unstemmed Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas
title_short Treatment Strategies in 135 Consecutive Patients with Enterocutaneous Fistulas
title_sort treatment strategies in 135 consecutive patients with enterocutaneous fistulas
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248608/
https://www.ncbi.nlm.nih.gov/pubmed/18175171
http://dx.doi.org/10.1007/s00268-007-9371-1
work_keys_str_mv AT visschersrubengj treatmentstrategiesin135consecutivepatientswithenterocutaneousfistulas
AT daminkstevenwmolde treatmentstrategiesin135consecutivepatientswithenterocutaneousfistulas
AT winkensbjorn treatmentstrategiesin135consecutivepatientswithenterocutaneousfistulas
AT soeterspeterb treatmentstrategiesin135consecutivepatientswithenterocutaneousfistulas
AT vangemertwimg treatmentstrategiesin135consecutivepatientswithenterocutaneousfistulas